Cargando…
DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours.
The level of expression of enzymes that can activate or detoxify bioreductive agents within tumours has emerged as an important feature in the development of these anti-tumour compounds. The levels of two such reductase enzymes have been determined in 19 human non-small-cell lung tumours and 20 huma...
Autores principales: | MarÃn, A., López de Cerain, A., Hamilton, E., Lewis, A. D., Martinez-Peñuela, J. M., Idoate, M. A., Bello, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228079/ https://www.ncbi.nlm.nih.gov/pubmed/9328153 |
Ejemplares similares
-
Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase
por: Wang, X, et al.
Publicado: (1999) -
Presence of a heterozygous substitution and its relationship to DT-diaphorase activity.
por: Kuehl, B. L., et al.
Publicado: (1995) -
EO9: relationship between DT-diaphorase levels and response in vitro and in vivo.
por: Collard, J., et al.
Publicado: (1995) -
Immunological Quantitation of DT‐Diaphorase in Carcinoma Cell Lines and Clinical Colon Cancers: Advanced Tumors Express Greater Levels of DT‐Diaphorase
por: Mikami, Koji, et al.
Publicado: (1998) -
DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.
por: Plumb, J. A., et al.
Publicado: (1994)